PSA's February 2026 Price Hike Details PSA implemented these psa grading price increases in February 2026 to match surging ...

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...

However, men with higher PSA levels did show modest improvements in survival, suggesting that hormone therapy might be worthwhile for them. PSA (prostate-specific antigen) is produced by the prostate ...

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative positron emission tomography (PET) radiopharmaceuticals, today announced results ...

Adding hormone therapy to postoperative radiotherapy did not improve OS for most patients ...

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...

Early trials of the drug VIR-5500 showed it shrinking tumours in some patients ...

About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.

We came across a bullish thesis on Public Storage on R. Dennis’s Substack by OppCost. In this article, we will summarize the ...

Early cancer screening in Bengaluru helps detect breast, ovarian and prostate cancers sooner.

Stage and screen actor Robert Lindsay, 76, is the 100,000th signature to the petition calling for prostate cancer screening ...

BioNTech and partner DualityBio are accelerating the development of their B7-H3 antibody-drug conjugate into a phase 3 trial for metastatic castration-resistant prostate cancer (mCRPC). | BioNTech and ...